The eye health supplements market was valued at US$ 1,572.33 million in 2019 and is projected to reach US$ 2,382.96 million by 2027; it is expected to grow at a CAGR of 5.5% from 2020 to 2027.
Increasing prevalence of eye diseases and rising number of geriatric population are among the major factors fueling the growth of this market.Moreover, increasing industrial developments are expected to foster market growth during the forecast period.
However, the high cost of eye health supplements and lack of product availability hinder the growth of the eye health supplements market.Additionally, the APAC countries are facing challenges due to the rising incidences of COVID-19.
As per the data of Worldometer, the total number of COVID-19 cases stood at 5,739,512 in APAC on August 17, 2020.The COVID-19 pandemic has accelerated the dependency on digital devices and consumers are becoming aware of the effects of prolonged use of these devices such as mobile and laptops.
Due to these factors millennials are spending more on eye supplements.
Eye supplements are nutritional products that help maintain eye health and good vision.The eye health supplements prominently comprise vitamin A, lutein and zeaxanthin, omega-3 fatty acids, gamma-linolenic acid, and others.
These nutritional supplements help sustain eye function, reduce the development of age-related eye diseases, and protect eyes from harmful radiations.
The global eye health supplements market is segmented by ingredient type, indication, and form.Based on ingredient type, the market is segmented into lutein and zeaxanthin, antioxidants, omega-3 fatty acids, coenzyme Q10, flavonoids, astaxanthin, alpha-lipoic acid, and others.
The lutein and zeaxanthin segment held the largest share of the market in 2019.However, the flavonoids segment is anticipated to register the highest CAGR during the forecast period.
Based on indication, the eye health supplements market is segmented into age-related macular degeneration (AMD), cataract, dry eye syndrome, and others.The age-related macular degeneration (AMD) segment held the largest share of the market in 2019.
However, the dry eye syndrome segment is anticipated to register the highest CAGR during the forecast period. Based on form, the eye health supplements market is segmented into tablet, capsule, and drops. The capsule segment held the largest share of the market in 2019 and is estimated to grow at the fastest CAGR during 2020-2027.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and American Academy of Ophthalmology are a few primary and secondary sources that were studied while preparing this report.
Our reports have been used by over 10K customers, including:
194 pages •
By Global Industry Analysts
• Jul 2020
Global Lutein Market to Reach $411.6 Million by 2027 Amid the COVID-19 crisis, the global market for Lutein estimated at US$289.6 Million in the year 2020, is projected to reach a revised size of US$411.6 Million by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Food, one of the segments analyzed in the report,...
The nutraceutical ingredients market is projected to grow at a CAGR of 7.0%. The nutraceutical ingredients market is estimated to be valued at USD 162.1billion in 2020 and is projected to reach USD 227.5billion by 2025, at a CAGR of 7.0% from 2020 to 2025.The growth of the nutraceutical ingredients market is driven by factors such as growth...
Macular Degeneration Global Clinical Trials Review, H2, 2020 Summary Clinical trial report, “Macular Degeneration Global Clinical Trials Review, H2, 2020" provides an overview of Macular Degeneration Clinical trials scenario.This report provides top line data relating to the clinical trials on Macular...
Retinopathy Of Prematurity - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Retinopathy Of Prematurity - Pipeline Review, H2 2020, provides an overview of the Retinopathy Of Prematurity (Ophthalmology) pipeline landscape. Retinopathy of prematurity...
200 pages •
By The Business Research Company
• Sep 2020
Major players in the antiglaucoma drug market are Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare and Johnson & Johnson. The global antiglaucoma drugs market is expected to decline from $6.6 billion in 2019 to $5.2 billion in 2020 at a compound annual growth rate (CAGR) of -21.3%. The decline is mainly due to the...
Uveitis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Uveitis - Pipeline Review, H2 2020, provides an overview of the Uveitis (Ophthalmology) pipeline landscape. Uveitis is swelling and irritation of the uvea, the middle layer of the eye....
Glaucoma - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Glaucoma - Pipeline Review, H2 2020, provides an overview of the Glaucoma (Ophthalmology) pipeline landscape. Glaucoma is a disease of the eye in which fluid pressure within the eye...
Spirulina Market Research Report by Type (Arthrospira Maxima and Arthrospira Platensis), by Drug Formulation (Granule & Gelling Agent, Liquid, Powder, and Tablet & Capsule), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Spirulina Market is expected to grow from USD 294.67 Million...
Herbal Supplements Market Research Report by Function (Aroma and Medicinal), by Form (Capsules & Tablets, Oils, Powder, and Syrups), by Source, by Supplier Type, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Herbal Supplements Market is expected to grow from USD 9,450.78 Million...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.